The global market for 3D printing in healthcare is on a path of exponential growth, driven by technological advancements and increasing demand for personalised healthcare solutions. According to the latest report published by the analyst the market is projected to surpass US$14 Bn in revenue by 2030, at a robust CAGR of 19.8% during the forecast period, 2023 to 2030. The report intends to explore key trends and growth drivers identified in the report, shedding light on the evolving landscape of 3D printing in the healthcare industry.
The report summary can be provided as below:
Moreover, 3D printing enables a patient-specific approach, allowing for the creation of custom-made medical devices, implants, and prostheses tailored to individual patients' needs. This personalised approach not only improves patient outcomes but also enhances overall patient satisfaction.
Moreover, investments in training, education, and research across key Asian nations are likely to fuel the adoption of 3D printing technology in the healthcare sector. Japan and Korea are expected to be at the forefront of this growth, embracing innovative healthcare solutions enabled by 3D printing.
3D Systems Corporation, Stratasys Ltd, EOS GmbH, TeVido Biodevices, Precision ADM, Might Oak Medical, Allevi (BioBots), Exone Company, General Electric, Formlabs Inc., Materialise N.V., Organovo Holdings Inc., Oxford Performance Materials Inc., CELLINK, Proto Labs, SLM Solutions Group AG, Rokit, and Cellbricks are some of the prominent players steering the competition landscape of the 3D printing in healthcare market space.
The report summary can be provided as below:
- Polymers remain the dominant material segment, but the demand for biomaterials is emerging as a lucrative opportunity.
- Jetting technologies are expected to experience rapid growth, and biomanufacturing holds tremendous potential in the personalised healthcare sector.
- The report identifies biomanufacturing as an emerging opportunity hub in the 3D printing in healthcare market.
- The rapid advancements in 3D bioprinting technology have revolutionised the field of tissue engineering, opening doors for the creation of artificial organs and tissues.
- 3D bioprinting is expected to play a pivotal role in the personalised healthcare sector, offering potential life-saving solutions for patients suffering from burns and other critical conditions.
Advantages of Additive Manufacturing Drive Adoption
The adoption of 3D printing technology in healthcare is rising due to several key advantages it offers. One of the primary benefits is the ability to reduce manufacturing costs, making it an attractive option for healthcare providers and medical device manufacturers. The potential for bulk manufacturing further enhances cost-effectiveness and scalability.Moreover, 3D printing enables a patient-specific approach, allowing for the creation of custom-made medical devices, implants, and prostheses tailored to individual patients' needs. This personalised approach not only improves patient outcomes but also enhances overall patient satisfaction.
Segmentation Analysis
Material Preferences Inclined Toward Biomaterials
The report highlights that polymers continue to dominate the market as the leading material segment, accounting for over a billion-dollar revenue. However, the demand for biomaterials is expected to witness significant growth, with a projected CAGR of nearly 20.3% between 2023 and 2030. Biomaterials offer unique properties that make them more suitable for specific medical applications, further driving their adoption in the healthcare industry.Demand for Implants and Prosthesis on the Rise
In terms of application, the implants and prostheses segment spearheads the market, contributing over US$1.2 Bn in revenue. This segment is driven by the increasing prevalence of chronic diseases and the aging population, leading to a higher demand for medical implants and prosthetic devices.Jetting Technologies is a Fast-growing Market Segment
The report highlights that jetting technologies, including binder jetting and material jetting, are expected to witness the fastest growth in the medical models segment. These technologies address the growing need for greater accuracy and precision in medical device manufacturing and research. As jetting technologies gain preference over other conventional medical models, their applications are likely to expand significantly in the coming years.Regional Outlook
Asia Pacific Emerges as a Growth Leader
The report provides regional analysis, revealing exciting growth prospects for the adoption of 3D printing in healthcare across Asia Pacific. The region is expected to witness a stupendous CAGR of approximately 21% during the forecast period. This growth can be attributed to several factors, including the region's major cost benefits in terms of labour and raw materials.Moreover, investments in training, education, and research across key Asian nations are likely to fuel the adoption of 3D printing technology in the healthcare sector. Japan and Korea are expected to be at the forefront of this growth, embracing innovative healthcare solutions enabled by 3D printing.
Competition Analysis and Key Market Players
The report includes a comprehensive competition analysis, examining the technological advancements and innovations driving the market. Detailed vendor summaries, strategic developments, product mapping, capability analysis, regional foothold, and economic analysis are covered in the analysis.3D Systems Corporation, Stratasys Ltd, EOS GmbH, TeVido Biodevices, Precision ADM, Might Oak Medical, Allevi (BioBots), Exone Company, General Electric, Formlabs Inc., Materialise N.V., Organovo Holdings Inc., Oxford Performance Materials Inc., CELLINK, Proto Labs, SLM Solutions Group AG, Rokit, and Cellbricks are some of the prominent players steering the competition landscape of the 3D printing in healthcare market space.
Table of Contents
1. Executive Summary
2. Market Overview
3. Global 3D Printing in Healthcare Market Outlook, 2019 - 2030
4. North America 3D Printing in Healthcare Market Outlook, 2019 - 2030
5. Europe 3D Printing in Healthcare Market Outlook, 2019 - 2030
6. Asia Pacific 3D Printing in Healthcare Market Outlook, 2019 - 2030
7. Rest of the World 3D Printing in Healthcare Market Outlook, 2019 - 2030
8. Competitive Landscape
9. Appendix
Companies Mentioned
- 3D Systems, Inc.
- Stratasys LTD
- Materialise NV
- General Electric Company
- Organovo Holdings Inc
- Formlabs
- 3T Additive Manufacturing Ltd
- 3D Bioprinting Solutions
- Aspect Biosystems
- BICO
- CELLINK
Methodology
LOADING...